References
- Hamidi M, Azadi A, Rafiei P. (2008). Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev, 60:1638–1649.
- Vaghani SS, Patel MM. (2011). pH-sensitive hydrogels based on semi-interpenetrating network (semi-IPN) of chitosan and polyvinyl pyrrolidone for clarithromycin release. Drug Dev Ind Pharm, 37:1160–1169.
- Zhang LL, Li P, Li YM, Wang AQ. (2012). Preparation and characterization of magnetic alginate-chitosan hydrogel beads loaded matrine. Drug Dev Ind Pharm, 38:872–882.
- Jung T, Kamm W, Breitenbach A, Kaiserling E, Xiao JX, Kissel T. (2000). Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur J Pharm Biopharm, 50:147–160.
- Hu X, Jing X. (2009). Biodegradable amphiphilic polymer-drug conjugate micelles. Expert Opin Drug Deliv, 6:1079–1090.
- Lu Z, Chen W, Hamman JH. (2010). Chitosan-polycarbophil interpolyelectrolyte complex as a matrix former for controlled release of poorly water-soluble drugs I: in vitro evaluation. Drug Dev Ind Pharm, 36:539–546.
- Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. (2008). Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J Control Release, 125:193–209.
- Upadhyay KK, Agrawal HG, Upadhyay C, Schatz C, Le Meins JF, Misra A et al. (2009). Role of block copolymer nanoconstructs in cancer therapy. Crit Rev Ther Drug Carrier Syst, 26:157–205.
- Prabaharan M, Grailer JJ, Steeber DA, Gong S. (2008). Stimuli-responsive chitosan-graft-poly(N-vinylcaprolactam) as a promising material for controlled hydrophobic drug delivery. Macromol Biosci, 8:843–851.
- Ganta S, Devalapally H, Shahiwala A, Amiji M. (2008). A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release, 126:187–204.
- Arias JL, López-Viota M, Gallardo V, Adolfina Ruiz M. (2010). Chitosan nanoparticles as a new delivery system for the chemotherapy agent tegafur. Drug Dev Ind Pharm, 36:744–750.
- Wang XL, Huang Y, Zhu J, Pan YB, He R, Wang YZ. (2009). Chitosan-graft poly(p-dioxanone) copolymers: preparation, characterization, and properties. Carbohydr Res, 344:801–807.
- Chen MC, Wong HS, Lin KJ, Chen HL, Wey SP, Sonaje K et al. (2009). The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin. Biomaterials, 30:6629–6637.
- Lin YH, Chang CH, Wu YS, Hsu YM, Chiou SF, Chen YJ. (2009). Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy. Biomaterials, 30:3332–3342.
- Nguyen MK, Lee DS. (2010). Injectable biodegradable hydrogels. Macromol Biosci, 10:563–579.
- Leucuta SE. (2010). Nanotechnology for delivery of drugs and biomedical applications. Curr Clin Pharmacol, 5:257–280.
- Li P, Zhang N. (2011). Layer-by-layer self-assembly vectors for gene delivery. Curr Gene Ther, 11:58–73.
- Nagpal K, Singh SK, Mishra DN. (2010). Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull, 58:1423–1430.
- Saha RN, Vasanthakumar S, Bende G, Snehalatha M. (2010). Nanoparticulate drug delivery systems for cancer chemotherapy. Mol Membr Biol, 27:215–231.
- Giannotti MI, Esteban O, Oliva M, García-Parajo MF, Sanz F. (2011). pH-responsive polysaccharide-based polyelectrolyte complexes as nanocarriers for lysosomal delivery of therapeutic proteins. Biomacromolecules, 12:2524–2533.
- Oyarzun-Ampuero FA, Brea J, Loza MI, Alonso MJ, Torres D. (2012). A potential nanomedicine consisting of heparin-loaded polysaccharide nanocarriers for the treatment of asthma. Macromol Biosci, 12:176–183.
- Codée JD, Stubba B, Schiattarella M, Overkleeft HS, van Boeckel CA, van Boom JH et al. (2005). A modular strategy toward the synthesis of heparin-like oligosaccharides using monomeric building blocks in a sequential glycosylation strategy. J Am Chem Soc, 127:3767–3773.
- Jee KS, Park HD, Park KD, Kim YH, Shin JW. (2004). Heparin conjugated polylactide as a blood compatible material. Biomacromolecules, 5:1877–1881.
- Luppi E, Cesaretti M, Volpi N. (2005). Purification and characterization of heparin from the Italian clam Callista chione. Biomacromolecules, 6:1672–1678.
- Suk JY, Zhang F, Balch WE, Linhardt RJ, Kelly JW. (2006). Heparin accelerates gelsolin amyloidogenesis. Biochemistry, 45:2234–2242.
- Hamidi M, Shahbazi MA, Rostamizadeh K. (2012). Copolymers: efficient carriers for intelligent nanoparticulate drug targeting and gene therapy. Macromol Biosci, 12:144–164.
- Shahbazi MA, Santos HA. (2012). Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication. Curr Drug Metab.
- Li XY, Li X, Kong XY, Shi S, Guo G, Zhang J et al. (2010). Preparation of N-trimethyl chitosan-protein nanoparticles intended for vaccine delivery. J Nanosci Nanotechnol, 10:4850–4858.
- Santander-Ortega MJ, Peula-García JM, Goycoolea FM, Ortega-Vinuesa JL. (2011). Chitosan nanocapsules: Effect of chitosan molecular weight and acetylation degree on electrokinetic behaviour and colloidal stability. Colloids Surf B Biointerfaces, 82:571–580.